Updated NCCN pediatric STS guidelines emphasize risk stratification, imaging, multimodal therapy, and clinical trial enrollment to improve outcomes. The National Comprehensive Cancer Network (NCCN) ...

Rates of survival throughout the years in soft tissue sarcoma with synchronous metastases: Results of a population-based study. Correlation between a new growth modulation index (GMI)-based Geistra ...

Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus 131I-Tositumomab: Long-Term Follow-Up of Phase III ...

The National Comprehensive Cancer Network ® (NCCN ® ) today published new NCCN Clinical Practice Guidelines in Oncology (NCCN ...

Synovial sarcoma is a rare, aggressive malignancy with deceptive benign presentation, complicating diagnosis and delaying treatment. Molecular confirmation of SS18-SSX fusion genes is crucial for ...

At Huntsman Cancer Institute, you receive comprehensive, multidisciplinary care for soft-tissue sarcomas. Our Sarcoma Care Team provides personalized and compassionate care at every step, from ...

Alveolar soft part sarcoma (ASPS) is a rare soft-tissue sarcoma with a poor prognosis and no established therapy. Recently, encouraging responses to immune checkpoint inhibitors have been reported. We ...

Soft tissue sarcoma is a type of cancerous tumor that forms in the body’s soft tissues, such as muscle, fat, fibrous tissue, and blood vessels. If it occurs in the shoulder, it might feel like a ...

Soft tissue sarcoma (STS) is a type of cancer that develops in soft tissues, such as deep skin tissues, muscle, fat, and blood vessels. STS can occur in any part of the body, including the abdomen.

Soft tissue sarcomas are cancers that develop in your body’s soft tissues like muscle, fat, tendons, or cartilage. Your legs are the most common place they develop. The American Cancer Society ...